NBW Capital LLC Has $5.72 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

NBW Capital LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 10,858 shares of the healthcare conglomerate’s stock after purchasing an additional 328 shares during the period. NBW Capital LLC’s holdings in UnitedHealth Group were worth $5,716,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in UNH. Moneta Group Investment Advisors LLC raised its position in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter worth about $5,210,004,000. Arrowstreet Capital Limited Partnership raised its position in UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares in the last quarter. International Assets Investment Management LLC raised its position in UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares in the last quarter. Finally, Barclays PLC raised its position in UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after purchasing an additional 2,058,829 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 3.4 %

NYSE UNH traded up $16.30 on Thursday, reaching $495.29. The company had a trading volume of 5,342,172 shares, compared to its average volume of 4,474,133. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The stock’s 50 day moving average is $489.51 and its 200-day moving average is $515.38. The stock has a market cap of $456.62 billion, a price-to-earnings ratio of 30.39, a PEG ratio of 1.28 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the company earned $6.26 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $569.68.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.